EHL BIO Awards and Recognitions: A Leader in Regenerative Medicine Innovation

Quick answer

EHL BIO is widely recognized through prestigious awards such as the 'IR52 Jang Young-shil' and the Ministry of Health and Welfare Award. It is notably the first in Korea to be authorized as a Human Cell Management Business (CPC) under the highest standards of MFDS.

Key takeaways

Awarded the 2025 IR52 Jang Young-shil Industrial Technology Innovation Award for KDSTEM®.
Received the Ministry of Health and Welfare Award in 2024 for contributions to advanced regenerative medicine.
First in Korea to receive Human Cell Management Business (CPC) certification from MFDS.
Holds patents for high-purity cell isolation and culturing technologies from both adipose tissue and urine.

National Honors: A Testament to Cutting-Edge Innovation

EHL BIO has been honored at the highest levels in the Republic of Korea. In 2025, the company received the prestigious 'IR52 Jang Young-shil Award,' which recognizes Korea's most outstanding industrial innovations, for the development of KDSTEM®, a urine-derived stem cell (UDSC) therapy aimed at recovery and quality of life for chronic kidney conditions.

Furthermore, in 2024, the Ministry of Health and Welfare of Korea presented EHL BIO with the 'Minister of Health and Welfare Award' to acknowledge its pivotal role in driving the advanced regenerative medicine industry. These achievements reflect the relentless efforts of over 85 researchers to establish new standards for health care.

GMP Standards and Global Certifications

Quality and safety are at the core of EHL BIO. Our Cell Center is certified under GMP (Good Manufacturing Practices) by the Korean Ministry of Food and Drug Safety (MFDS) and was the first in South Korea to be authorized as a Cell Processing Center (CPC).

Confidence in our standards is internationally recognized. Our cell isolation, cultivation, and storage processes within Class 100 laboratory environments are of high quality and safe according to standards, supporting a production capacity of 6,000 lots per year for patients across our network of 100+ partner hospitals in Korea and in Thailand for recovery and quality of life goals.

Our awards and certifications are not just a source of pride, but a commitment to the goals of recovery and improved quality of life for every client.

Leading Patents and Intellectual Property

EHL BIO stands out with proprietary technologies protected by multiple patents, such as the 15-PGDH Inhibitor for cardiovascular recovery goals and a highly efficient SVF isolation system from adipose tissue. We also hold patents for culturing high-purity urine-derived stem cells, a non-invasive innovation showing satisfactory results in kidney care.

Our cell culture technology can increase cell count while maintaining cell viability and properties excellently under a -196°C cryopreservation system. These patents are the key to EHL BIO emerging as a leader in biotechnology.

Recognition Through Research and Government Projects

EHL BIO’s medical advancements are recognized through consistent selection for the Korean Fund for Regenerative Medicine (KFRM) projects in 2022 and 2024, receiving funding to advance KDSTEM clinical trials for chronic kidney conditions into Phases 1 and 2.

Additionally, the Phase 2 clinical results for ADSTEM in caring for atopic dermatitis were published in a prestigious international journal in 2025. This confirms the efficacy and safety as assessed by the EHL team and experts, reinforcing that our work is built upon credible scientific foundations.

Frequently asked questions

Which organizations have certified EHL BIO?

We are GMP-certified by the Korean MFDS and have received CPC approval from the Korean Ministry of Health.

What are the goals for recovery and quality of life with EHL BIO's innovations?

We focus on using cell technology for bodily recovery and enhancing quality of life, featuring KDSTEM® with its outstanding urine-derived cell isolation technology which received Korea's IR52 Jang Young-shil award.

Can hospitals in Thailand access EHL BIO's innovations?

EHL Thailand has a dedicated Thai coordination team to facilitate medical evaluations and travel planning for services at the EHL Cell Clinic in Korea.